UBS lowered the firm’s price target on Albemarle to $109 from $124 and keeps a Neutral rating on the shares. After a review of price and volume trends and updates on chemical spreads and prices, the firm’s Q2 estimates are reduced about 2% in aggregate across its North American Chemicals coverage, the analyst tells investors in an earnings preview note for the group.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALB: